Heart-Lung Transplantation

Subscribe to Selected New Research on Heart-Lung Transplantation

449 relevant articles (13 outcomes, 20 trials/studies) found for this Therapy

Description: The simultaneous, or near simultaneous, transference of heart and lungs from one human or animal to another.

Also Known As:

Grafting, Heart Lung; Graftings, Heart-Lung; Heart Lung Transplantation; Heart-Lung Grafting; Heart-Lung Graftings; Heart-Lung Transplantations; Transplantation, Heart Lung; Transplantations, Heart-Lung; Grafting, Heart-Lung; Transplantation, Heart-Lung

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 4

Transplantation: 36585

Organ Transplantation: 2370

Heart Transplantation: 5054

Heart-Lung Transplantation: 449

Lung Transplantation: 2851

Heart-Lung Transplantation: 449

Thoracic Surgical Procedures: 43

Cardiac Surgical Procedures: 202

Heart Transplantation: 5054

Heart-Lung Transplantation: 449

Pulmonary Surgical Procedures: 3

Lung Transplantation: 2851

Heart-Lung Transplantation: 449

Cardiovascular Surgical Procedures: 18

Cardiac Surgical Procedures: 202

Heart Transplantation: 5054

Heart-Lung Transplantation: 449

Experts

1.	Robbins, Robert C: 3 articles (10/2006 - 07/2002)
2.	Vricella, Luca A: 2 articles (10/2006 - 07/2002)
3.	Wallwork, J: 2 articles (12/2005 - 12/2001)
4.	Large, S R: 2 articles (12/2005 - 12/2001)
5.	Kramer, Mordechai R: 2 articles (05/2005 - 01/2003)
6.	Shitrit, David: 2 articles (05/2005 - 01/2003)
7.	Izbicki, Gabriel: 2 articles (05/2005 - 01/2003)
8.	Haverich, A: 2 articles (09/2002 - 10/2000)
9.	Franke, T: 2 articles (09/2002 - 10/2000)
10.	Wahlers, T: 2 articles (09/2002 - 10/2000)

Related Diseases

1.	Cystic Fibrosis (Mucoviscidosis) 05/01/1996 - "CONCLUSION: Despite the presence of airway pathogens, these results confirm that heart-lung transplantation for cystic fibrosis leads to a pronounced improvement in lung function and good rehabilitation after surgery" 11/01/1993 - "The study provides evidence that patients with end-stage respiratory disease caused by cystic fibrosis gain a survival advantage and improvement in quality of life after heart-lung transplantation when compared with patients who do not receive this form of therapy." 12/01/1992 - "CONCLUSIONS: Cystic fibrosis bronchi obtained at heart-lung transplantation provide a viable source of tissue for in vitro studies of bioelectric properties" 12/01/1992 - "The feasibility of in vitro studies of bioelectric properties and ion fluxes in lower airways, obtained at heart-lung transplantation from patients with cystic fibrosis, has been assessed" 06/01/2005 - "Lung versus heart-lung transplantation for cystic fibrosis: is the debate still open?" Get all the results and reference details, order at left...
2.	Pulmonary Hypertension (Ayerza Syndrome) 05/01/1997 - "These relatively larger animals are valuable for further studies of single, double, bilateral, and heart-lung transplantation for pulmonary hypertension." 02/01/1994 - "After heart-lung transplantation, pathological studies of the explanted organs showed changes of thrombo-embolic pulmonary hypertension" 09/01/1987 - "Studies were performed measuring parameters of respiratory and circulatory function at rest and during maximum tolerable constant work rate treadmill exercise in 16 clinically well patients who had undergone heart-lung transplantation for end stage pulmonary hypertension" 09/01/2002 - "Heart-lung transplantation is the method of choice in the treatment of patients with end-stage pulmonary hypertension." 07/01/2001 - "Heart-lung transplantation is generally the only procedure available for patients whose pulmonary hypertension can not be reversed by conventional pharmacologic means" Get all the results and reference details, order at left...
3.	Lung Diseases (Lung Disease) 10/01/2001 - "Lung and heart-lung transplantation are currently recognized as effective treatment for selected patients with end-stage lung or heart-lung disease" 01/01/1991 - "As survival rates improve with improved management, lung and heart-lung transplantations are contributing towards effective treatment of end-stage pulmonary disease as well as providing new insight into pulmonary physiology and into mechanisms of lung disease." 04/01/2005 - "Heart-lung transplantation (HLT), followed by single lung transplantation (SLT) and subsequently bilateral lung transplantation (BLT) have been developed as treatments for patients with end-stage pulmonary diseases" 11/01/1998 - "Heart, lung, and combined heart-lung transplantations are no longer experimental procedures; they are a standard part of the treatment algorithm for selected patients with end-stage heart and lung disease" 12/01/1996 - "At our Department of Cardiac Surgery, the preliminary experience in lung replacement was obtained by clinically applying heart-lung transplantation in patients with both vascular and parenchymal lung disease during 1991" Get all the results and reference details, order at left...
4.	Infection 04/01/2001 - "STUDY OBJECTIVES: Acute rejection and cytomegalovirus (CMV) infection are important complications after lung and heart--lung transplantation" 04/01/2005 - "CONCLUSIONS: Reasons for cardiothoracic procedures after prior heart or heart-lung transplantation were allograft vasculopathy, aortic dissections years after transplantation, chronic rejection, and either lung infections or malignancies" 12/01/2003 - "It is a common sequela of bone marrow, lung, and heart-lung transplantation, but can also occur as a complication of certain pulmonary infections, adverse drug reaction, toxic inhalation, and autoimmune disorders" 06/27/2003 - "Human herpesvirus-6 infection after lung and heart-lung transplantation: a prospective longitudinal study." 07/01/1997 - "CONCLUSIONS: Indices of ventilation distribution, FEF25-75, and TLC have the best optimal sensitivity for the diagnosis of infection and rejection after heart-lung transplantation" Get all the results and reference details, order at left...
5.	Bronchiolitis 02/01/1991 - "Further studies on the natural history of obliterative bronchiolitis following heart-lung transplantation." 08/01/2003 - "Obliterative bronchiolitis (OB) affects over half of all survivors following lung or heart-lung transplantation" 12/01/2002 - "Obliterative bronchiolitis (OB) affects over half of all chronic human survivors following lung or heart-lung transplantation" 08/01/2000 - "The pathogenesis of obliterative bronchiolitis (OB) following lung and heart-lung transplantation remains unclear" 06/01/2000 - "Obliterative bronchiolitis (OB) is the major long-term complication following lung and heart-lung transplantation" Get all the results and reference details, order at left...
166 Diseases and 449 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Cyclosporine (Ciclosporin)
2.	Adrenal Cortex Hormones (Corticosteroids)
3.	Prostaglandins I
4.	Epoprostenol (Prostacyclin)
5.	Oxygen
6.	tranilast (N 5')
7.	Iron (Serum Iron Level)
8.	Immunoglobulin Gm Allotypes
9.	Free Radicals
10.	p-Aminosalicylic Acid (PAS)
47 Drugs and Important Bio-Agents and 50 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Transplantation (Transplant Recipients)
2.	Transplants (Transplant)
3.	Lung Transplantation
4.	Homologous Transplantation (Allograft)
5.	Heart Transplantation (Grafting, Heart)
34 Therapies and Procedures and 109 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>